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Introduction 
Dengue is one of the many mosquito born diseases, belonging to a class of 
flaviviruses. Other viruses that also belong to this class are Zika and Japanese 
Encephalitis (JE). Aedes aegypti female mosquitoes serve as vectors that transmit these 
viruses from individual to individual. As expected Dengue fever is endemic in many 
warm places such as Southeast Asia, South America, and warmer parts of Africa. 
Recently, dengue has spread to other warmer regions in North America such Florida, 
Texas, and Hawaii. In 2012, dengue rose by 70% in the United States, most likely 
attributed to rising global temperatures (Thanks, Global Warming--Mosquito-Borne 
Diseases Are on the Uptick, 2013). 
In addition to dengue’s spread throughout the world, the demographics of people 
affected with dengue have also changed. Original known as a pediatric disease, in the 
past two decades, dengue has penetrated the older population. The result has been an 
increase in more severe dengue secondary infections. Primary infections(first 
contractions) are usually less severe, even asymptomatic at times. Secondary 
infections(second time contracting dengue) are usually much more severe because of 
antibody cross reactivity. Given that dengue has four serotypes, there is a relatively high 
likelihood of contracting other dengue serotypes even though one may have contracted a 
primary infection and subsequently became immune to that specific serotype (Hasan, 
Shamimul et al., 2016). However, it is important to note that a dengue secondary 
infection does not constitute that the patient has contracted dengue for the second time. It 
can also mean that the individual has had other flaviviruses infected them before. For 
instance, if an individual had the JE vaccine as a child and later contracted dengue for the 
first time, serology tests would suggest that he/she had a secondary infection.  
As dengue becomes more prevalent in adults, studies show that adult and child 
dengue patients exhibit different symptoms. There has been research done to identify 
unique symptoms that disproportionately manifest in each age group. Hanufasa S., et al., 
(2008) conducted a study in Rayong, Thailand found that headache and myalgia were 
more common in adults while coughing, vomiting, abdominal pain and rash were more 
common in children. With almost identical findings, a similar study in Brazil found that 
myalgia, retro-orbital pain, nausea, arthralgia were more common in adults while 
vomiting and skin rash were more common in children (Souza, L. J., et al, 2013).  Both 
studies found similar patterns of symptoms that manifested in adults and children. They 
both found myalgia to be more common in adults and vomiting and skinrash to be more 
common in children. Perhaps much of this could be related to the fact that adults develop 
secondary infections while children develop symptoms from primary infections. Despite 
identifying these symptoms as more common in a certain age group, there has not been a 
model to predict whether a set of symptoms can clearly identify the age group of a 
dengue patient. 
My research aims to develop a satisfactory model that predicts whether the 
dengue patient is an adult or child based on a set of symptoms. This model can aid 
doctors in differentiating symptoms between adult dengue from child dengue patients.  
There are many types of models that one can build. Specifically for this analysis, I 
built a decision tree. The reason I used a decision tree is so that doctors can input the 
symptoms of a patient and determine visually based on the model whether the patient is a 
child or an adult.   
The main question here is if adult and child dengue patients consistently manifest 
different symptoms and if the same set of symptoms appear in each class is consistent 
enough for a model to accurately predict whether a dengue patient is a child or adult 
based on their symptoms. My hypothesis is that the model that I develop will be able to 
accurately predict whether a dengue patient is a child or an adult since adults and children 
tend to exhibit different symptoms. 
To evaluate this model, I will use evaluation measures, including an ROC curve, 
area under the ROC curve, accuracy, precision, f-measure, and recall.  
 
Methods 
I acquired s dataset used in this study through Armed Forces Research Institute of 
Medical Sciences (AFRIMS). The dataset has a collection of approximately 7,000 
potential dengue patients in Kamphaeng Phet, Thailand from 2007-2015. Included in the 
dataset are PCR results, serology test results, age, location of blood collection, and 
various symptoms manifested in those patients.  
To analyze all this data, I used RStudio. First I determined which patient had 
dengue. PCR results were the main indicator of whether a patient had dengue. If PCR 
was positive, then there would be no reason to consider serology. If PCR was negative, 
then serology results were used to determine whether the patient had a dengue infection. 
If the patient had a dengue positive serology result, then I classified the patient as dengue 
positive. Dengue positive patients were grouped as 1 while dengue negative patients were 
grouped as 0.  
 
 
 
 
 
 
 
 
Removal of “N/A”s was done only rows with really sparse data. Another 
important classification is to determine whether a patient was a child or adult. Adults 
were classified as >15 years of age. The flow chart below describes how I classified 
patients in the dataset.  
To analyze the data, I generated a boxplot, showing the average age of dengue 
patients from 2007-2015. I then generated a histogram to display the proportion of 
dengue serotypes by year. To analyze the differences in symptoms between adults and 
children, I filtered the dataset for dengue patients only; then I made histograms showing 
the proportion of children with certain symptoms in relation to adults. This was done for 
cough, muscle pain, eye pain, headache, skinrash, nausea, vomiting, diarrhea, abdominal 
pain, and jointpain. I analyzed these symptoms specifically because Souza, L. J., et al,. , 
(2013) and Hanufasa S., et al., (2008) found age bias in these symptoms. 
After preliminary symptom analysis, to predict the difference in symptoms 
between adults and children, I used a classifier called a decision tree. I also used 10 fold 
cross-validation to ensure generalizability of the model. Once this was done I evaluated 
the model with confusion matrices. With the confusion matrix, I made Receiving 
Operating Characteristic (ROC) curves, calculated accuracy, precision, f-measure, recall 
and area under the ROC curve. 
Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Figure 1 and 2, we observe a median age range of 13.5-17 from 2007-2015.  
 
 
Figure	1-Median	age	of	all	dengue	patients	each	year	from	2007-2015.		The	median	age	is	stable	
throughout.	 
  
 
 
 
 
 
 
Although the median age is stable across the years of analysis, the standard deviation has 
increased from 8.15 to 12.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure	2-Median	age	of	dengue	patients	each	year.	Though	the	median	age	is	stable	throughout	2007-2015,	
the	spread	has	been	increasing.	 
Figure	3-There	are	4	serotypes	in	this	histogram:	Dengue-	1,2,3	and	4.	The	histogram	displays	the	
proportion	of	each	serotype	by	year.	 
 Figure 3 displays the proportion of each Dengue serotype by year. Dengue-1 was the 
predominant strain affecting dengue patients in 2007. From 2008-2012, we see a general 
increase in Dengue-2. Starting 2013, we observe a sudden increase in Dengue-3. Dengue-
3 levels continue to rise until 2015 at which point we see a sudden increase in Dengue-4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
In Figure 4, I developed histograms to visualize the proportion of adult and dengue 
patients with certain symptoms. In this figure, I included the following symptoms: 
jointpain, diarrhea, cough, skinrash, nausea, abdominal pain, headache, vomiting, muscle 
pain, and eye pain. Based on the histograms above, jointpain, skinrash, nausea, headache, 
muscle pain, and eye pain affected more adults than children. Diarrhea and cough 
affected both children and adults equally. Lastly, abdominal pain and vomiting affected 
more children than adults, although not by much.  
 
 
 
 
 
 
 
 
 
Figure	4-Histograms	of	symptoms	exhibited	in	adult		Vs.	dengue	patients. 
Figure	5-	Decision	Tree	to	determine	whether	the	dengue	patient	is	an	adult	or	child	based	on	
symptoms.	TRUE	represents	proportion	of	adults	in	the	prediction	and	FALSE	represents	the	proportion	
of	children	in	the	prediction.	 
 Figure 5 displays one of the decision trees generated through 10 fold cross validation. 
“TRUE” and “FALSE” at the end of the nodes represent “Adults” and “Children” 
respectively. This CART model was developed based on the training data, nine out of the 
ten segmented portions of the dataset. The sequence of symptoms demonstrates the 
proportion of adults and children with that specific set of symptoms.  
 
 
 
 
 
 
Figure 6 is an example of a confusion matrix taken from the first cross-validation. 
“Prediction” is the model’s predictions whether the patient is a child or adult based on 
their symptoms. These predictions were matched against true classes of child or adults in 
the test set. In this confusion matrix, we observe many false negatives; true values that 
were predicted as false. For instance, there are 106 true predictions, 99 false negatives, 
194 true negatives, and 48 false positives.  
 
 
 
 
 
Figure	7-The	Receiving	Operator	Characteristic	(ROC)	curve	plots	the	true	positive	
predictions	against	the	false	positive	predictions.			
Figure	6-The	confusion	matrix	counts	the	number	of	actual	true	and	false	predictions	as	well	as	
false	negatives	and	false	positives	based	on	the	decision	tree.		
  
The ROC (Receiving Operator Characteristic) Curve plots true positive predictions 
against false positive predictions. The ratio of true positives to false positive is 
approximately 2.  
 
 
 
 
 
 
 
 
With the confusion matrix, numerous evaluation measures were employed to determine 
the predictive ability of the model. Figure 8 displays the average of all evaluation 
measures. The average accuracy, precision, recall, f-measure, and area under the ROC 
curve are 0.66, 0.67, 0.72, 0.69, and 0.70. All of these evaluation measures were 
calculated from the average of all confusion matrices.   
 
Discussion 
Based on my data analysis, median age of infection from 2007-2015 hovered 
around14-17, although the standard deviation has increased from ~8 to ~12 overtime. 
Evaluation Measures 
Accuracy 0.66 
Precision 0.67 
Recall 0.72 
F-measure 0.69 
Area Under the Curve 0.70 
Figure 8-This table displays the average accuracy, precision, recall, f-measure, and the area under the curve of 
the AUC curves. This average is obtained by doing a 10-fold cross validation.  
Simmons, C. P., & Farrar, J. , (2009) found the median age of dengue infections in 
Thailand increased from 13-17 from 1999-2005. Since 2005, my analysis suggests that 
the median age has stayed in the same range. However, the spread increased throughout 
the years, suggesting that a greater proportion of adults are contracting the disease. What 
was known as a pediatric disease has become a more widespread phenomenon among 
adults.  
 As more adults become infected, there is a greater likelihood of developing 
dengue secondary infections by nature of probability. There are two types of dengue 
fever: apparent and inapparent. Inapparent dengue patients have the virus, but exhibit no 
symptoms. Apparent dengue fever is the opposite of inapparent. Thus when one has 
inapparent dengue, the immune system still produces antibodies against the dengue virus. 
As antibody levels build up, the body develops resistance against the serotype that 
infected the person. When the individual again contracts another strain of the Dengue 
virus, they have higher chances of developing secondary infections. When a secondary 
infection occurs, the body overreacts and produces excess antibodies, enhancing the 
inflammatory response in the body, describing a process called Antibody-Dependent 
Enhancement (ADE). During this antibody overdrive, the body produces non-neutralizing 
antibodies, which bind to the virus RNA without deactivating them (Goncalvez et al., 
2007). As a result, these non-neutralizing antibodies carry these infectious particles 
throughout the body, into different tissues. The end result is that there is increased 
inflammation around tissues in which Dengue viruses were transported.  
Also equally important is the shift in serotype trends from 2007-2015. In 2007, 
we observe predominantly Dengue-1 presence. However, we observe a quick shift to 
Dengue-2 from 2008-2012. Once again we see another serotype shift to Dengue-3 from 
2013-15 with some rising Dengue-4 in 2015. Fried, Jessica R, et al., (2010) found 
Dengue 2 and 3 to be associated with Dengue Hemorraghic Fever, which is a severe form 
of Dengue Fever. However, Dengue-1 is associated with milder forms of Dengue. We 
might suspect here that the severity of dengue infections has increased throughout the 
years in our sample. At the same time, the number of adult dengue patients has also 
increased, suggesting potential link between age and serotype. We suspect that Dengue-2 
and 3 mutate much more quickly than other strains, making them much more virulent and 
likely to infect people who may have had inapparent dengue as children. This area is 
research largely unknown and genomic analyses of dengue serotypes need to be done. 
The trend towards greater presence of Dengue-4 in 2015 is intriguing and is worth 
following to see whether Dengue-4 will develop into a virulent strain as well in the 
coming years.  
With increasing age diversity in dengue patients, adults and children manifest 
different symptoms. Studies conducted in Brazil and Thailand found headache, myalgia, 
retro-orbital pain, nausea and arthralgia to be more common in adults. Symptoms 
predominately found in children are cough, vomiting, abdominal pain, and skin rash. 
(Hanafusa S., et al. ,2008 & Souza L. J., et al., 2013). My analysis, however, only 
partially supports these findings. Not only did joint pain, nausea, headache, muscle pain, 
and eye pain affected more adults than children, but skin rash was also more prevalent in 
adults than in children. Yet based on Hanafusa S., et al. ,2008 & Souza L. J., et al., 
(2013), skinrash should have been the predominant symptom in children. In terms of 
typical child dengue symptoms, in accord with literature, my analysis suggests that 
abdominal pain and vomiting are more common in children. Coughing, which was 
supposed to be a pediatric symptom affected children and adults equally in my analysis. 
This could be the result of regional differences.  
To further determine the difference in symptoms between children and adults, I 
made a decision tree to predict whether the patient is an adult or child based on their 
symptom profile. I then evaluated the model and made a confusion matrix, shown in 
Figure 6. Since there are 100 true predictions to 99 false positive predictions, which is not 
ideal, we know that there is some overfitting in the model. In other words, the model in 
Figure 5 is not able to make generalized predictions on the test set, and incorrectly 
classifies an adult more than it should have.  
Figure 7 further evaluates the model by plotting true positives against false 
positives. Ideally, we want a steep curve, suggesting a high ratio of positive rate to false 
positive rate. However, we observe here a relative flat curve. Looking at the evaluation 
measures more closely, Figure 8 displays the accuracy, recall, precision, f-measure, and 
AUC.  Our accuracy is 0.66 which is rather low, as well as our precision 0.67. However, 
our recall is 0.72, which should not be discounted. A higher recall suggests that model is 
better at minimizing false negatives than false positives. A false negative in this case 
would be if the actual class were adult, but the model predicted that the patient was a 
child; while a false positive would be the opposite. Having a high recall works to our 
benefit because we are more interested in adults in the first place. Our AUC value was 
0.7, which was not bad either. AUC values can range from 0-1. Ideally for us to 
definitively use a set of symptoms to classify adults or children, we would need an AUC 
value of 0.95 or more.  
This project is far from complete, and in the future, I would use other classifiers 
to predict the classes. Other classifiers that may be useful for predicting age group are 
Naïve Bayes and linear regression. If those two classifiers can better predict our classes, 
then it most likely means that our model is not the best model for this classification task, 
and that there was overfitting in our model. However, if other models did not perform 
better than our current decision tree, then perhaps the difference in symptoms between 
adults and children was not that significant. After all, there could be too much variability 
in how symptoms manifest in adult and child dengue patients.  
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